Search
news › baylor-researchers-awarded-1-6m-to-investigate-mass-spec-test-for-thyroid-cancer
… in funding to validate a mass spectrometry-based test for diagnosis of thyroid fine needle aspiration (FNA) … a final diagnosis which is associated with risk, cost, and complications for the patient. In 2019, Dr. Eberlin and Dr. Suliburk … Researchers Awarded $1.6M to Investigate Mass Spec Test for Thyroid Cancer …
healthcare › clinical-trials › h-47159
… Biomarker In Patients Undergoing Neoadjuvant Therapy For Resectable Non-Small Cell Lung Cancer … of employing quantitative ctDNA as a surrogate marker for pathologic treatment response in patients receiving neoadjuvant therapy for Stage IIA-IIIB NSCLC undergoing curative-intent …
news › broadly-diverse-genomes-study-reveals-new-susceptibility-genetic-variants-for-lung-cancer
… College of Medicine identifies new genetic risk factors for lung cancer. The cross-ancestry genome-wide association … tended to be specific to populations. Even some commonly known risk factors such as the CHRNA5 and CYP2A6 … for population and quantitative science at the Dan L Duncan Comprehensive Cancer Center at Baylor. For a full list of …
news › clinical-trial-to-improve-prognosis-for-pancreatic-cancer-patients-now-enrolling-patients
… medical director of medical oncology at the Dan L Duncan Comprehensive Cancer Center, are now enrolling patients in a … clinical trial with the potential to improve the prognosis for patients with pancreatic cancer. “Through this study, … in cancers such as lung and breast cancer have shown that a combination of immune checkpoint therapy administered …
news › study-shows-synergistic-association-between-genetic-and-behavioral-risks-for-liver-disease
… alcohol use and obesity are known to increase the risk for developing cirrhosis and liver cancer, but the risk is not the same for everyone with those factors. Researchers at Baylor … PNPLA3, plays a synergistic role in increasing the risk for cirrhosis, liver cancer and liver-related death when …
news › simple-rapid-and-robust-method-makes-mouse-whole-organs-transparent-for-imaging
… The adage ‘Seeing is believing’ was front of mind for Dr. Chih-Wei Logan Hsu and Dr. Joshua D. Wythe at Baylor … Cancer Center and the Cardiovascular Research Institute . “For instance, researchers can now visualize neuronal … said. “Then, they can bring the cleared organ to the OiVM for 3D imaging and analysis.” Other contributors to this …
news › researchers-reveal-a-map-to-study-novel-form-of-cell-to-cell-communication
… resource to study extracellular RNA (exRNA), a novel form of cell-to-cell communication. The study, published in … act as a messenger carrying instructions encoded in the DNA for the synthesis of proteins,” said co-corresponding … understanding exRNA biology and provide new opportunities for the development of exRBP/exRNA liquid biopsy …
news › baylor-college-of-medicine-honors-faculty-for-2023-excellence-in-patient-care
… Baylor College of Medicine has recognized physicians for their excellence in patient care through its annual … consistent high level of patient care, professionalism, commendable leadership skills and service to the community. “It is an honor for me each year to recognize …
healthcare › clinical-trials › h-54023
… An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men … (greater than or equal to six months ago) on AI in combination with either palbociclib or ribociclib as first …
news › a-grant-of-her-own-the-women-scientists-innovation-award-for-cancer-research
… a Grant of Her Own: The Women Scientists Innovation Award for Cancer Research for Dr. Eberlin’s pioneering work with the MassSpec Pen … for precise margin assessment. Dr. Eberlin’s team is committed to refining this technology for clinical trials … A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research …